{
    "Disease activity (follow up: 9 months; assessed with: ACR 20)": {
        "No of studies": "1",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["serious", "b"],
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "56/63 (88.9%)",
            "Abruptly withdraw DMARDs": "48/63 (76.2%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 1.17 (0.99 to 1.37)",
            "Absolute (95% CI)": "130 more per 1,000 (from 8 fewer to 282 more)"
        },
        "Certainty": "⨁⨁◯◯ LOW",
        "Importance": "CRITICAL"
    },

    "Disease activity (follow up: 9 months; assessed with: ACR 50)": {
        "No of studies": "1",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious", "c"],
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "49/63 (77.8%)",
            "Abruptly withdraw DMARDs": "45/63 (71.4%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 1.09 (0.89 to 1.34)",
            "Absolute (95% CI)": "64 more per 1,000 (from 79 fewer to 243 more)"
        },
        "Certainty": "⨁◯◯◯ VERY LOW",
        "Importance": "CRITICAL"
    },

    "Disease activity (follow up: 9 months; assessed with: ACR 70)": {
        "No of studies": "1",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious", "c"],
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "45/63 (71.4%)",
            "Abruptly withdraw DMARDs": "39/63 (61.9%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 1.15 (0.90 to 1.48)",
            "Absolute (95% CI)": "93 more per 1,000 (from 62 fewer to 297 more)"
        },
        "Certainty": "⨁◯◯◯ VERY LOW",
        "Importance": "CRITICAL"
    },

    "Disease activity (follow up: 9 months; assessed with: DAS28-ESR (Lower values – > benefit) (MCID -1.17)": {
        "No of studies": "1",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["serious", "b"],
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "63",
            "Abruptly withdraw DMARDs": "65"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": "MD 0.7 lower (1.25 lower to 0.15 lower)"
        },
        "Certainty": "⨁⨁◯◯ LOW",
        "Importance": "CRITICAL"
    },

    "Remission (follow up: 9 months; assessed with: DAS28ESR < 2.6)": {
        "No of studies": "1",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": "not serious",
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "50/63 (79.4%)",
            "Abruptly withdraw DMARDs": "35/65 (53.8%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 1.47 (1.14 to 1.91)",
            "Absolute (95% CI)": "253 more per 1,000 (from 75 more to 490 more)"
        },
        "Certainty": "⨁⨁⨁◯ MODERATE",
        "Importance": "CRITICAL"
    },

    "Flare (follow up: 12 months)": {
        "No of studies": "2",
        "Study design": "randomised trials",
        "Risk of bias": "not serious",
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious", "d"],
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "3/126 (2.4%)",
            "Abruptly withdraw DMARDs": "10/79 (12.7%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 0.19 (0.05 to 0.66)",
            "Absolute (95% CI)": "103 fewer per 1,000 (from 120 fewer to 43 fewer)"
        },
        "Certainty": "⨁⨁◯◯ LOW",
        "Importance": "CRITICAL"
    },

    "Radiographic progression (follow up: 9 months; assessed with: mTSS (Lower values – > benefit) (MCID 4.6)": {
        "No of studies": "1",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": "not serious",
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "63",
            "Abruptly withdraw DMARDs": "65"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": "MD 0.1 higher (0.34 lower to 0.54 higher)"
        },
        "Certainty": "⨁⨁⨁◯ MODERATE",
        "Importance": "IMPORTANT"
    },

    "Quality of Life (follow up: 9 months; assessed with: SF-36 PCS (Higher values – > benefit) (MCID 4.4)": {
        "No of studies": "3",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["serious", "b"],
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "63",
            "Abruptly withdraw DMARDs": "65"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": ["MD 2.3 higher (0.47 lower to 5.07 higher)", "e"]
        },
        "Certainty": "⨁⨁◯◯ LOW",
        "Importance": "IMPORTANT"
    },

    "Quality of Life (follow up: 9 months; assessed with: SF-36 MCS (Higher values – > benefit) (MCID 3.1)": {
        "No of studies": "3",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["serious", "b"],
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "63",
            "Abruptly withdraw DMARDs": "65"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": ["MD 1.8 higher (0.97 lower to 4.57 higher)", "f"]
        },
        "Certainty": "⨁⨁◯◯ LOW",
        "Importance": "IMPORTANT"
    },

    "Fatigue (follow up: 9 months; assessed with: FACIT-F (Higher values – > benefit) (MCID 15.9)": {
        "No of studies": "3",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": "not serious",
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "63",
            "Abruptly withdraw DMARDs": "65"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": "MD 1.8 higher (1.25 lower to 4.85 higher)"
        },
        "Certainty": "⨁⨁⨁◯ MODERATE",
        "Importance": "IMPORTANT"
    },

    "Withdrawal due to adverse events (follow up: 9 months)": {
        "No of studies": "1",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious", "d"],
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "3/63 (4.8%)",
            "Abruptly withdraw DMARDs": "0/65 (0.0%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 7.22 (0.38 to 136.98)",
            "Absolute (95% CI)": "0 fewer per 1,000 (from 0 fewer to 0 fewer)"
        },
        "Certainty": "⨁◯◯◯ VERY LOW",
        "Importance": "IMPORTANT"
    },

    "Serious adverse events (follow up: 9 months)": {
        "No of studies": "1",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious", "d"],
        "Other considerations": "none",
        "Nº of patients": {
            "Taper off DMARDs": "3/63 (4.8%)",
            "Abruptly withdraw DMARDs": "2/65 (3.1%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 1.55 (0.27 to 8.95)",
            "Absolute (95% CI)": "17 more per 1,000 (from 22 fewer to 245 more)"
        },
        "Certainty": "⨁◯◯◯ VERY LOW",
        "Importance": "IMPORTANT"
    }
}